Open the map

Becton DickinsonBDX

Medtech & devices · NYSE · USA

$182.75
Up 1.4% todayClose

Up 18.1% this year and +17.2% since June 26, ahead of the life science sector at +10.7%. Becton Dickinson supplies 2 mapped companies.

This year
+18.1%
1 year
+19.0%
P/E
51.8
P/S
2.3
P/B
2.0

Price vs the life science sector

since Jun 26BDXLife science sector, equal weight
Becton Dickinson (BDX) vs the Life science sector indexDaily closes from Jun 26, 2026 to Oct 8, 2026, each line rebased to its own first value. BDX: +17.2% from Jun 26, 2026 to Oct 8, 2026. Life science sector index: +10.7% from Jun 26, 2026 to Oct 8, 2026.0%+10%+20%Jun 26AugSepOct 8BDX +17.2%Sector +10.7% Becton Dickinson (BDX) vs the Life science sector indexDaily closes from Jun 26, 2026 to Oct 8, 2026, each line rebased to its own first value. BDX: +17.2% from Jun 26, 2026 to Oct 8, 2026. Life science sector index: +10.7% from Jun 26, 2026 to Oct 8, 2026.0%+10%+20%Jun 26AugSepOct 8BDX+17.2%Sector+10.7%

Supply chain

2 customers
SUPPLIERS →→ CUSTOMERSNone mappedLabcorp (LH)LHLabcorp+0.7%Cardinal Health (CAH)CAHCardinal Health+2.9%BDXBecton Dickinson Open the full chain →

About Becton Dickinson

Syringes and needles sit at the recognisable end of the range. Becton Dickinson's portfolio is broad, spanning medical consumables alongside diagnostic systems and drug delivery equipment.

Theme exposure

MedtechDiagnostics exposureMedical consumablesDiagnosticsDrug delivery

Products

  • Medical consumables
  • Diagnostic systems
  • Drug delivery

Competitors

Risks

  • Mature markets
  • Announced business split

Same segment: Medtech & devices

Medical equipment and devices, from surgery and cardiology to robotics. Segment 7 of 8 in the Medicine, pharma & life science value chain.

Compare BDX

Side by side with the largest companies in the same segment.

See where Becton Dickinson sits in the full Medicine, pharma & life science map: every segment from upstream suppliers to end markets, with daily metrics.

Open the Life science value chain →